Andreas Kogelnik: Difference between revisions

From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
VisualWikitext
m (Undo revision 110726 by Notjusttired (talk))
m (Text replacement - "author-link8 = | last8" to "author-link7 = | last8")
 
(133 intermediate revisions by the same user not shown)
Line 1: Line 1:
  [[File:Andreas Kogelnik.png|thumb|right|Source: www.openmedicinefoundation.org]]
  [[File:Andreas Kogelnik.png|thumb|right|Source: www.openmedicinefoundation.org]]
'''Andreas ("Andy") M. Kogelnik''', MD, PhD, is an [[internal medicine]] and [[Infectious disease|infectious diseases]] specialist and the director of the [[Open Medicine Institute]], Mountain View, California, US.<ref name=":0">{{Cite web|url=http://www.openmedicineinstitute.org/the-clinic.html|title=The Clinic|website=Open Medicine Institute|language=en|access-date=2019-04-17}}</ref> His interests are in [[bioinformatics]] and [[genomic]] medicine and is committed to the study and treatment of [[ME/CFS]] and other chronic illnesses.<ref name=":0" />
'''Andreas ("Andy") M. Kogelnik''', MD, PhD, is an [[internal medicine]] and [[Infectious disease|infectious diseases]] specialist and the director of the [[Open Medicine Institute]], Mountain View, California, US.<ref name=":0">{{Cite web | url = http://www.openmedicineinstitute.org/the-clinic.html | title = The Clinic | website = Open Medicine Institute|language=en | access-date = 2019-04-17}}</ref> His interests are in [[bioinformatics]] and [[genomic]] medicine and is committed to the study and treatment of [[ME/CFS]] and other chronic illnesses.<ref name=":0" />


==Education==
==Education==
Line 10: Line 10:


==ME/CFS Common Data Element (CDE) Project==
==ME/CFS Common Data Element (CDE) Project==
Kogelnik is a member of the Immune Working Group of the [[ME/CFS|Myalgic Encephalomyelitis/Chronic Fatigue Syndrome]] Common Data Element (CDE) Project, sponsored by the [[National Institute of Neurological Disorders and Stroke]] and the [[Centers for Disease Control and Prevention]].<ref>{{Cite web|url=https://www.commondataelements.ninds.nih.gov/Myalgic%20Encephalomyelitis/Chronic%20Fatigue%20Syndrome#pane-138|title=Complete Myalgic Encephalomyelitis/Chronic Fatigue Syndrome CDE Roster|last=|first=|authorlink=|date=|website=NIH|archive-url=|archive-date=|url-status=|access-date=2019-10-11}}</ref>
Kogelnik is a member of the Immune Working Group of the [[ME/CFS|Myalgic Encephalomyelitis/Chronic Fatigue Syndrome]] Common Data Element (CDE) Project, sponsored by the [[National Institute of Neurological Disorders and Stroke]] and the [[Centers for Disease Control and Prevention]].<ref>{{Cite web | url = https://www.commondataelements.ninds.nih.gov/Myalgic%20Encephalomyelitis/Chronic%20Fatigue%20Syndrome#pane-138 | title = Complete Myalgic Encephalomyelitis/Chronic Fatigue Syndrome CDE Roster | last = | first = | author-link = | date = | website = NIH|archive-url=|archive-date=|url-status= | access-date = 2019-10-11}}</ref>


==Research publications on ME/CFS==
==Research publications on ME/CFS==


*2006, Use of [[valganciclovir]] in patients with elevated antibody titers against [[Human herpesvirus 6|Human Herpesvirus-6]] (HHV-6) and [[Epstein-Barr virus|Epstein-Barr Virus]] (EBV) who were experiencing central nervous system dysfunction including long-standing fatigue<ref>{{Cite journal|last=Kogelnik|first=AM|author-link=Andreas Kogelnik|last2=Loomis|first2=K|last3=Hoegh-Petersen|first3=M|last4=Rosso|first4=F|last5=Hischier|first5=C|last6=Montoya|first6=JG|author-link6=Jose Montoya|date=|title=Use of valganciclovir in patients with elevated antibody titers against Human Herpesvirus-6 (HHV-6) and Epstein-Barr Virus (EBV) who were experiencing central nervous system dysfunction including long-standing fatigue|url=https://www.ncbi.nlm.nih.gov/pubmed/17276366|journal=Journal of Clinical Virology|volume=37|pages=Suppl 1:S33-8|doi=10.1016/S1386-6532(06)70009-9|pmid=17276366|via=}}</ref> - [https://www.ncbi.nlm.nih.gov/pubmed/17276366 (Abstract)]
*2006, Use of [[valganciclovir]] in patients with elevated antibody titers against [[Human herpesvirus 6|Human Herpesvirus-6]] (HHV-6) and [[Epstein-Barr virus|Epstein-Barr Virus]] (EBV) who were experiencing central nervous system dysfunction including long-standing fatigue<ref>{{Cite journal | last = Kogelnik | first = AM | author-link = Andreas Kogelnik | last2 = Loomis | first2 = K | last3 = Hoegh-Petersen | first3 = M | last4 = Rosso | first4 = F | last5 = Hischier | first5 = C | last6 = Montoya | first6 = JG | author-link6 = Jose Montoya | date = | title = Use of valganciclovir in patients with elevated antibody titers against Human Herpesvirus-6 (HHV-6) and Epstein-Barr Virus (EBV) who were experiencing central nervous system dysfunction including long-standing fatigue | url =https://www.ncbi.nlm.nih.gov/pubmed/17276366 | journal = Journal of Clinical Virology | volume = 37| pages=Suppl 1:S33-8|doi=10.1016/S1386-6532(06)70009-9|pmid=17276366|via=}}</ref> - [https://www.ncbi.nlm.nih.gov/pubmed/17276366 (Abstract)]
*2011, No evidence of murine-like gammaretroviruses in [[Chronic fatigue syndrome|CFS]] patients previously identified as XMRV-infected<ref>{{Cite journal|last=Knox|first=K.|last2=Carrigan|first2=D.|last3=Simmons|first3=G.|last4=Teque|first4=F.|last5=Zhou|first5=Y.|last6=Hackett|first6=J.|last7=Qiu|first7=X.|last8=Luk|first8=K.-C.|last9=Schochetman|first9=G.|last10=Kogelnik|first10=AM|author-link10=Andreas Kogelnik|date=2011-07-01|title=No Evidence of Murine-Like Gammaretroviruses in CFS Patients Previously Identified as XMRV-Infected|url=http://www.sciencemag.org/cgi/doi/10.1126/science.1204963|journal=Science|language=en|volume=333|issue=6038|pages=94–97|doi=10.1126/science.1204963|issn=0036-8075}}</ref> - [https://science.sciencemag.org/content/333/6038/94.long (Full text)]
*2011, No evidence of murine-like gammaretroviruses in [[Chronic fatigue syndrome|CFS]] patients previously identified as XMRV-infected<ref>{{Cite journal | last = Knox | first = K. | last2 = Carrigan | first2 = D. | last3 = Simmons | first3 = G. | last4 = Teque | first4 = F. | last5 = Zhou | first5 = Y. | last6 = Hackett | first6 = J. | last7 = Qiu | first7 = X. | last8 = Luk | first8 = K.-C. | last9 = Schochetman | first9 = G. | last10 = Kogelnik | first10 = AM | author-link10 = Andreas Kogelnik | date = 2011-07-01 | title = No Evidence of Murine-Like Gammaretroviruses in CFS Patients Previously Identified as XMRV-Infected | url =http://www.sciencemag.org/cgi/doi/10.1126/science.1204963 | journal = Science|language=en | volume = 333 | issue = 6038 | pages = 94–97|doi=10.1126/science.1204963|issn=0036-8075}}</ref> - [https://science.sciencemag.org/content/333/6038/94.long (Full text)]
*2013, Randomized Clinical Trial to Evaluate the Efficacy and Safety of [[Valganciclovir]] in a Subset of Patients With [[Chronic Fatigue Syndrome]]<ref name="Montoya, 2013" /> - [https://onlinelibrary.wiley.com/doi/full/10.1002/jmv.23713 (Full text)]
*2013, Randomized Clinical Trial to Evaluate the Efficacy and Safety of [[Valganciclovir]] in a Subset of Patients With [[Chronic Fatigue Syndrome]]<ref name="Montoya, 2013" /> - [https://onlinelibrary.wiley.com/doi/full/10.1002/jmv.23713 (Full text)]
*2017, Multi-Site Clinical Assessment of [[ME/CFS|Myalgic Encephalomyelitis/Chronic Fatigue Syndrome]] (MCAM): Design and Implementation of a Prospective/Retrospective Rolling Cohort Study<ref name="Unger, 2017" /> - [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5565838/ (Full text)]
*2017, Multi-Site Clinical Assessment of [[ME/CFS|Myalgic Encephalomyelitis/Chronic Fatigue Syndrome]] (MCAM): Design and Implementation of a Prospective/Retrospective Rolling Cohort Study<ref name="Unger, 2017" /> - [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5565838/ (Full text)]
Line 25: Line 25:
==Talks and interviews==
==Talks and interviews==


*May 2011 - Keynote Speaker at the 6th [[Invest in ME International ME Conference]] - Speech Title: ''Strategies for ME Research and Collaboration''<ref>{{Cite web|url=http://investinme.org/cindex.shtml|title=Invest in ME Research - UK Charity for Myalgic Encephalomyelitis Centre of Excellence for ME Blog|website=investinme.org|access-date=2019-07-16}}</ref>
*May 2011 - Keynote Speaker at the 6th [[Invest in ME International ME Conference]] - Speech Title: ''Strategies for ME Research and Collaboration''<ref>{{Cite web | url = http://investinme.org/cindex.shtml | title = UK Charity for Myalgic Encephalomyelitis Centre of Excellence for ME Blog | website = investinme.org | access-date = 2019-07-16}}</ref>


:*[http://www.investinme.org/IIMEC6.shtml#dvd 2011 Conference DVD]
:*[http://www.investinme.org/IIMEC6.shtml#dvd 2011 Conference DVD]
Line 40: Line 40:
:[https://www.youtube.com/watch?v=GYaSNgbjs8E Interview with Dr. Andreas Kogelnik, Part 2]  
:[https://www.youtube.com/watch?v=GYaSNgbjs8E Interview with Dr. Andreas Kogelnik, Part 2]  


*2012, 7th [[Invest in ME International ME Conference]] - ''Strategies for ME Research and Collaboration''<ref>{{Cite web|url=http://investinme.org/cindex.shtml|title=Invest in ME Research - UK Charity for Myalgic Encephalomyelitis Centre of Excellence for ME Blog|website=investinme.org|access-date=2019-07-16}}</ref>
*2012, 7th [[Invest in ME International ME Conference]] - ''Strategies for ME Research and Collaboration''<ref>{{Cite web | url = http://investinme.org/cindex.shtml | title = UK Charity for Myalgic Encephalomyelitis Centre of Excellence for ME Blog | website = investinme.org | access-date = 2019-07-16}}</ref>


:*[http://www.investinme.org/IIMEC7.shtml#dvd 2012 Conference DVD]
:*[http://www.investinme.org/IIMEC7.shtml#dvd 2012 Conference DVD]


*2013, 8th [[Invest in ME International ME Conference]] Keynote Speaker: ''Strategies for ME Research and Collaboration''<ref>{{Cite web|url=http://investinme.org/cindex.shtml|title=Invest in ME Research - UK Charity for Myalgic Encephalomyelitis Centre of Excellence for ME Blog|website=investinme.org|access-date=2019-07-16}}</ref>
*2013, 8th [[Invest in ME International ME Conference]] Keynote Speaker: ''Strategies for ME Research and Collaboration''<ref>{{Cite web | url = http://investinme.org/cindex.shtml | title = UK Charity for Myalgic Encephalomyelitis Centre of Excellence for ME Blog | website = investinme.org | access-date = 2019-07-16}}</ref>


:*[http://www.investinme.org/IIMEC8.shtml#dvd 2013 Conference DVD]
:*[http://www.investinme.org/IIMEC8.shtml#dvd 2013 Conference DVD]
Line 60: Line 60:
==References==
==References==
<references>
<references>
<ref name="Montoya, 2013">{{Citation
<ref name="Montoya, 2013">{{Citation | last  = Montoya | first1 = JG | author-link1 = Jose Montoya | last2 = Kogelnik | first2 = AM | author-link2 = Andreas Kogelnik | last3 = Bhangoo | first3 = M | author-link3 = | last4 = Lunn | first4 = MR | author-link4 = | last5 =Flamand | first5 = L | author-link5 = | last6 = Merrihew | first6 = LE | author-link6 = | last7 =Watt | first7 = T | author-link7 = | last8 = Kubo | first8 = JT | author-link8 = | last9 =Paik | first9 = J | author-link9 = | last10= Desai | first10 = M | author-link10 = | title = Randomized clinical trial to evaluate the efficacy and safety of valganciclovir in a subset of patients with chronic fatigue syndrome. | journal = Journal of Medical Virology | volume = 85 | issue = 12 | page = 2101-9 | date = 2013 | pmid = 23959519 | doi = 10.1002/jmv.23713 }}</ref>
| last1  = Montoya         | first1 = JG             | authorlink1 = Jose Montoya
<ref name="Unger, 2017">{{Citation | last  = Unger | first1 = Elizabeth R. | author-link1 = Elizabeth Unger | last2 = Lin | first2 = Jin-Mann S. | author-link2 = Jin-Mann Sally Lin | last3 = Tian | first3 = Hao | author-link3 = | last4 = Natelson | first4 = Benjamin H | author-link4 = Benjamin Natelson | last5 =Lange | first5 = Gudrun | author-link5 = Gudrun Lange | last6 = Vu | first6 = Diana | author-link6 = | last7 =Blate | first7 = Michelle | author-link7 = | last8 = Klimas | first8 = Nancy G. | author-link8 = Nancy Klimas | last9 =Balbin | first9 = Elizabeth G. | author-link9 = Elizabeth Balbin | last10= Bateman | first10 = Lucinda | author-link10 = Lucinda Bateman | last11= Allen | first11 = Ali | author-link11 = | last12= Lapp | first12 = Charles W. | author-link12 = Charles Lapp | last13= Springs | first13 = Wendy | author-link13 = | last14= Kogelnik | first14 = Andreas M. | author-link14 = Andreas Kogelnik | last15= Phan | first15 = Catrina C. | author-link15 = | last16= Danver | first16 = Joan | author-link16 = | last17= Podell | first17 = Richard N. | author-link17 = Richard Podell | last18= Fitzpatrick | first18 = Trisha | author-link18 = | last19= Peterson | first19 = Daniel L. | author-link19 = Daniel Peterson | last20= Gottschalk | first20 = C. Gunnar | author-link20 = Gunnar Gottschalk | last21= Rajeevan | first21 = Mangalathu S. | author-link21 = Mangalathu Rajeevan | last22= MCAM Study Group | title = Multi-Site Clinical Assessment of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (MCAM): Design and Implementation of a Prospective/Retrospective Rolling Cohort Study. | journal = American Journal of Epidemiology | volume = 1-10 | issue = | page = | date = 2017 | pmid = | doi = 10.1093/aje/kwx029 }}</ref>
| last2   = Kogelnik       | first2 = AM             | authorlink2 = Andreas Kogelnik
| last3   = Bhangoo         | first3 = M               | authorlink3 =  
| last4   = Lunn           | first4 = MR             | authorlink4 =  
| last5   = Flamand         | first5 = L               | authorlink5 =  
| last6   = Merrihew       | first6 = LE             | authorlink6 =  
| last7   = Watt           | first7 = T               | authorlink7 =  
| last8   = Kubo           | first8 = JT             | authorlink8 =  
| last9   = Paik           | first9 = J               | authorlink9 =
| last10 = Desai           | first10 = M             | authorlink10 =
| title   = Randomized clinical trial to evaluate the efficacy and safety of valganciclovir in a subset of patients with chronic fatigue syndrome.
| journal = Journal of Medical Virology   | volume = 85   | issue = 12   | page = 2101-9
| date   = 2013
| pmid   = 23959519  
| doi     = 10.1002/jmv.23713
}}
</ref>
<ref name="Unger, 2017">{{Citation
| last1  = Unger       | first1 = Elizabeth R.   | authorlink1 = Elizabeth Unger
| last2   = Lin         | first2 = Jin-Mann S.     | authorlink2 = Jin-Mann Sally Lin
| last3   = Tian         | first3 = Hao             | authorlink3 =  
| last4   = Natelson     | first4 = Benjamin H     | authorlink4 = Benjamin Natelson  
| last5   = Lange       | first5 = Gudrun         | authorlink5 = Gudrun Lange
| last6   = Vu           | first6 = Diana           | authorlink6 =  
| last7   = Blate       | first7 = Michelle       | authorlink7 =  
| last8   = Klimas       | first8 = Nancy G.       | authorlink8 = Nancy Klimas
| last9   = Balbin       | first9 = Elizabeth G.   | authorlink9 = Elizabeth Balbin  
| last10 = Bateman     | first10 = Lucinda       | authorlink10 = Lucinda Bateman  
| last11 = Allen       | first11 = Ali           | authorlink11 =
| last12 = Lapp         | first12 = Charles W.     | authorlink12 = Charles Lapp  
| last13 = Springs     | first13 = Wendy         | authorlink13 =
| last14 = Kogelnik     | first14 = Andreas M.     | authorlink14 = Andreas Kogelnik  
| last15 = Phan         | first15 = Catrina C.     | authorlink15 =
| last16 = Danver       | first16 = Joan           | authorlink16 =
| last17 = Podell       | first17 = Richard N.     | authorlink17 = Richard Podell  
| last18 = Fitzpatrick | first18 = Trisha         | authorlink18 =
| last19 = Peterson     | first19 = Daniel L.     | authorlink19 = Daniel Peterson  
| last20 = Gottschalk   | first20 = C. Gunnar     | authorlink20 = Gunnar Gottschalk
| last21 = Rajeevan     | first21 = Mangalathu S. | authorlink21 = Mangalathu Rajeevan
| last22 = MCAM Study Group    
| title   = Multi-Site Clinical Assessment of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (MCAM): Design and Implementation of a Prospective/Retrospective Rolling Cohort Study.
| journal = American Journal of Epidemiology     | volume = 1-10   | issue =   | page =  
| date   = 2017
| pmid   =  
| doi     = 10.1093/aje/kwx029
}}
</ref>
</references>
</references>


Latest revision as of 19:54, July 29, 2023

Source: www.openmedicinefoundation.org

Andreas ("Andy") M. Kogelnik, MD, PhD, is an internal medicine and infectious diseases specialist and the director of the Open Medicine Institute, Mountain View, California, US.[1] His interests are in bioinformatics and genomic medicine and is committed to the study and treatment of ME/CFS and other chronic illnesses.[1]

Education[edit | edit source]

ME/CFS Common Data Element (CDE) Project[edit | edit source]

Kogelnik is a member of the Immune Working Group of the Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Common Data Element (CDE) Project, sponsored by the National Institute of Neurological Disorders and Stroke and the Centers for Disease Control and Prevention.[2]

Research publications on ME/CFS[edit | edit source]

Articles[edit | edit source]

Talks and interviews[edit | edit source]

The Open Medicine Institute, Part 1,
The Open Medicine Institute, Part 2,
The Open Medicine Institute, Part 3
Interview with Dr. Andreas Kogelnik, Part 1
Interview with Dr. Andreas Kogelnik, Part 2

References[edit | edit source]

  1. ↑ 1.0 1.1 1.2 1.3 1.4 1.5 "The Clinic". Open Medicine Institute. Retrieved April 17, 2019.
  2. ↑ "Complete Myalgic Encephalomyelitis/Chronic Fatigue Syndrome CDE Roster". NIH. Retrieved October 11, 2019.
  3. ↑ Kogelnik, AM; Loomis, K; Hoegh-Petersen, M; Rosso, F; Hischier, C; Montoya, JG. "Use of valganciclovir in patients with elevated antibody titers against Human Herpesvirus-6 (HHV-6) and Epstein-Barr Virus (EBV) who were experiencing central nervous system dysfunction including long-standing fatigue". Journal of Clinical Virology. 37: Suppl 1:S33-8. doi:10.1016/S1386-6532(06)70009-9. PMID 17276366.
  4. ↑ Knox, K.; Carrigan, D.; Simmons, G.; Teque, F.; Zhou, Y.; Hackett, J.; Qiu, X.; Luk, K.-C.; Schochetman, G.; Kogelnik, AM (July 1, 2011). "No Evidence of Murine-Like Gammaretroviruses in CFS Patients Previously Identified as XMRV-Infected". Science. 333 (6038): 94–97. doi:10.1126/science.1204963. ISSN 0036-8075.
  5. ↑ Montoya, JG; Kogelnik, AM; Bhangoo, M; Lunn, MR; Flamand, L; Merrihew, LE; Watt, T; Kubo, JT; Paik, J; Desai, M (2013), "Randomized clinical trial to evaluate the efficacy and safety of valganciclovir in a subset of patients with chronic fatigue syndrome.", Journal of Medical Virology, 85 (12): 2101-9, doi:10.1002/jmv.23713, PMID 23959519
  6. ↑ Unger, Elizabeth R.; Lin, Jin-Mann S.; Tian, Hao; Natelson, Benjamin H; Lange, Gudrun; Vu, Diana; Blate, Michelle; Klimas, Nancy G.; Balbin, Elizabeth G.; Bateman, Lucinda; Allen, Ali; Lapp, Charles W.; Springs, Wendy; Kogelnik, Andreas M.; Phan, Catrina C.; Danver, Joan; Podell, Richard N.; Fitzpatrick, Trisha; Peterson, Daniel L.; Gottschalk, C. Gunnar; Rajeevan, Mangalathu S.; MCAM Study Group (2017), "Multi-Site Clinical Assessment of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (MCAM): Design and Implementation of a Prospective/Retrospective Rolling Cohort Study.", American Journal of Epidemiology, 1–10, doi:10.1093/aje/kwx029
  7. ↑ "UK Charity for Myalgic Encephalomyelitis Centre of Excellence for ME Blog". investinme.org. Retrieved July 16, 2019.
  8. ↑ "UK Charity for Myalgic Encephalomyelitis Centre of Excellence for ME Blog". investinme.org. Retrieved July 16, 2019.
  9. ↑ "UK Charity for Myalgic Encephalomyelitis Centre of Excellence for ME Blog". investinme.org. Retrieved July 16, 2019.

chronic illness any long-term illness, regardless of the severity. Chronic illnesses are typically incurable, requiring long-term management.

antibodies Antibody/immunoglobulin refers to any of a large number of specific proteins produced by B cells that act against an antigen in an immune response.

central nervous system (CNS) - One of the two parts of the human nervous system, the other part being the peripheral nervous system. The central nervous system consists of the brain and spinal cord, while the peripheral nervous system consists of nerves that travel from the central nervous system into the various organs and tissues of the body.

National Institutes of Health (NIH) - A set of biomedical research institutes operated by the U.S. government, under the auspices of the Department of Health and Human Services.

myalgic encephalomyelitis (M.E.) - A disease often marked by neurological symptoms, but fatigue is sometimes a symptom as well. Some diagnostic criteria distinguish it from chronic fatigue syndrome, while other diagnostic criteria consider it to be a synonym for chronic fatigue syndrome. A defining characteristic of ME is post-exertional malaise (PEM), or post-exertional neuroimmune exhaustion (PENE), which is a notable exacerbation of symptoms brought on by small exertions. PEM can last for days or weeks. Symptoms can include cognitive impairments, muscle pain (myalgia), trouble remaining upright (orthostatic intolerance), sleep abnormalities, and gastro-intestinal impairments, among others. An estimated 25% of those suffering from ME are housebound or bedbound. The World Health Organization (WHO) classifies ME as a neurological disease.

Retrieved from "https://me-pedia.org/w/index.php?title=Andreas_Kogelnik&oldid=241586"